MAPS has not received any official FDA communication on MPG1. On 13 January, the FDA informed us with a brief courtesy email that the MPG1 protocol was not yet reviewed, and they hope to review it soon. Our interpretation is that the review division is overburdened in the midst of a global pandemic and as such have a review backlog.